The Bloomwell Group announced Monday it has successfully closed a seed funding round of over $10 million.
The lead investor is US growth capital provider Measure 8 Venture Partners, while Dr. Reinhard Meier opted to invest again through his Venture Capital Investors fund, with Philipp Weber of FPS acting as legal advisor to Bloomwell.
Simultaneously, the Bloomwell Group, which includes Algea Care, Europe's leading telemedicine company for medical cannabis in terms of patient numbers, said it is repositioning itself as a holding company, allowing it to build, invest or acquire cannabis companies.
Over the past year, the Frankfurt, Germany-based company has grown to 160 employees, with projected revenues of five million euros in 2021.
"Bloomwell Group is transforming the healthcare and medical cannabis market in Europe," Niklas Kouparanis, CEO and co-founder of Bloomwell Group, told Benzinga. "We have already seen success from our far-reaching D2C, direct-to-patient approach, and look forward to propelling the next generation of natural-based medicine forward. As the market continues to mature, our consumers will benefit from our portfolio companies' innovative and scalable solutions focused on digitalization."
Apart from Kouparanis, the company's board is strengthened by telemedicine veteran Dr. Meier, who as founder, led Teleclinic to an exit, Co-founder Samuel Menghistu and Boris Jordan, founding partner of Measure 8 Venture Partners, and founder and executive chairman at Curaleaf Holdings, Inc. CURA CURLF.
"Germany is the leading European market for medical cannabis, and the Bloomwell Group has proven within one year that it can identify and scale innovative solutions in this new growth market for the benefit of patients," Jordan said.
Massachusetts-based Curaleaf purchased EMMAC Life Sciences – now operating as Curaleaf International – in April in a $310 million deal to expand its footprint in Europe further.
Photo: Courtesy of Michael Longmire on Unsplash
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
